Objective To develop new antiphospholipid syndrome (APS) classification criteria with high specificity for use in observational studies and trials, jointly supported by the American College of ...

Mycophenolate is the mainstay of treatment for many organ and life-threatening manifestations of rheumatic and musculoskeletal diseases (RMD). In contrast to most patients with RMD, those taking ...

Objectives To evaluate efficacy and safety of immediate switch from upadacitinib to adalimumab, or vice versa, in patients with rheumatoid arthritis with non-response or incomplete-response to the ...

Correspondence to Dr Rishi J Desai, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts, USA; RDESAI{at}BWH.HARVARD.EDU Objectives Recent ...

Correspondence to Eloisa Bonfa, Rheumatology Division, Universidade de Sao Paulo Faculdade de Medicina, Sao Paulo 04746-070, Brazil; eloisa.bonfa{at}hc.fm.usp.br Objective To evaluate the effect on ...

Correspondence to Professor Zhuoli Zhang, Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China; zhuoli.zhang{at}126.com We conducted a real-world survey ...

Correspondence to Dr Robert Spiera, Department of Medicine, Hospital for Special Surgery, New York, NY 10028, USA; spierar{at}hss.edu There is a paucity of data on the effect of antirheumatic drugs on ...

3 Rheumatology unit, Department of Medicine, Karolinska Hospital, S-171 76 Stockholm, Sweden 4 Department of Public Health Sciences, Karolinska Institutet, S-171 77 Stockholm, Sweden Correspondence to ...